
Bleomycin Injection
| Product/Composition | Bleomycin Injection |
|---|---|
| Form | Injection |
| Strength | 15 units, 30 units |
| Therapeutic use | Anti Cancer |
| Package Insert/Leaflet | Available upon request |
Bleomycin Injection
-
Type: Anticancer (chemotherapy) medication
-
Drug Class: Antitumor antibiotic
-
Form: Injectable solution, usually given intravenously, intramuscularly, or subcutaneously
How It Works
-
Bleomycin binds to DNA in cancer cells and causes breaks in the DNA strands.
-
This stops the cancer cells from dividing and leads to cell death.
-
It is most effective during the G2 and M phases of the cell cycle (when cells are preparing to divide).
Common Uses
-
Hodgkin’s lymphoma (part of ABVD chemotherapy regimen)
-
Non-Hodgkin’s lymphoma
-
Testicular cancer
-
Squamous cell cancers (head, neck, cervix, skin)
-
Pleurodesis (treatment of recurrent pleural effusion — injected into the chest cavity to prevent fluid buildup)
Advantages
-
Very effective for certain cancers (especially testicular cancer and Hodgkin’s lymphoma)
-
Can be combined with other chemotherapy drugs for better outcomes
-
Has relatively low effect on bone marrow compared to many other chemotherapies
Possible Side Effects
-
Lung toxicity (most serious):
-
Pulmonary fibrosis or inflammation (cough, shortness of breath)
-
Risk increases with higher cumulative doses
-
-
Skin changes (darkening, thickening, rash)
-
Fever and chills after injection
-
Mouth sores
-
Nausea and vomiting
-
Hair loss (usually mild)
Precautions
-
Lung function tests are usually done before and during treatment
-
Total lifetime dose is limited to reduce risk of lung damage
-
Use caution in people with existing lung disease
-
Avoid high concentrations of supplemental oxygen during surgery (can worsen lung toxicity)
-
Requires administration by trained medical professionals